Posaconazole Tablet, Delayed Release
Product Images NDC 51407-676

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 51407-676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-676-60 (LABEL REV 08-22.jpg)

Posaconazole 100 mg delayed-release tablets label featuring the drug name and strength prominently. The label states the tablets are not interchangeable with Noxafil oral suspension, includes storage instructions, and a barcode. It is for 60 tablets, Rx only, manufactured by SpecGx LLC and marketed by GSMS, Incorporated in Camarillo, CA.*

FDA Label Image

Chemical Structure (Posaconazole Delayed Release Tablets 1)

Chemical structure of posaconazole, showing its molecular connectivity including fluorinated phenyl, triazole, and other heterocyclic rings typical of this antifungal agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.